ClinConnect ClinConnect Logo
Search / Trial NCT04014140

iFR Guided Coronary Artery Bypass Grafting Surgery

Launched by PRAKASH PUNJABI · Jul 4, 2019

Trial Information

Current as of July 27, 2025

Recruiting

Keywords

Instantaneous Wave Free Ratio (I Fr) Coronary Artery Bypass Grafting (Cabg)

ClinConnect Summary

This clinical trial is looking at how a special measurement called iFR (which checks blood flow in the heart) can help improve the success of coronary artery bypass grafting (CABG) surgery. The goal is to see if using iFR measurements before surgery leads to better results for patients' bypass grafts one year after the operation, compared to the standard method of assessing blockages through an angiogram (a type of imaging test).

To take part in this study, participants need to be between 25 and 80 years old, be undergoing their first elective CABG surgery, and be able to understand and sign the consent form. The trial is currently recruiting a small group of patients, between 28 and 100, and is focused on gathering data from a single center. If you join, you’ll have your heart examined using iFR before your surgery, and the researchers will track your progress for one year afterward to see how well your bypass grafts are functioning. This study could provide valuable insights into improving heart surgery outcomes for future patients.

Gender

ALL

Eligibility criteria

  • INCLUSION CRITERIA
  • 1. Age of 25 to 80 years of age
  • 2. Willing to participate and able to understand, read and sign the informed consent form (ICF) before standard of care elective CABG surgery
  • 3. Undergoing isolated first-time elective CABG surgery
  • 4. Available pre-operative angiography data with iFR measurements done during the pre-operative angiography
  • EXCLUSION CRITERIA
  • 1. Emergency CABG surgery
  • 2. Ejection Fraction≤ 40%
  • 3. Severe valvular heart disease

About Prakash Punjabi

Prakash Punjabi is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative clinical studies. With a focus on integrity and excellence, the organization collaborates with leading researchers and healthcare professionals to develop and implement rigorous trial protocols across diverse therapeutic areas. Prakash Punjabi emphasizes patient safety, ethical standards, and regulatory compliance, ensuring that all trials are conducted with the highest level of quality and transparency. By fostering partnerships and leveraging cutting-edge methodologies, Prakash Punjabi aims to contribute to the development of groundbreaking therapies that address unmet medical needs.

Locations

London, Greater London, United Kingdom

Patients applied

0 patients applied

Trial Officials

Prakash P Punjabi, MBBS,MCh,FRCS,FFST,FESC,FCCP

Principal Investigator

Imperial College Healthcare NHS Trust

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials